Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Specials
Spring Home & Garden Show
Home & Realty
Outdoor Guide
Women
Fall Home Improvement
Spring Wellness
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
2024 Auction
2024 Readersâ Choice Awards
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about BIIB
Recent news which mentions BIIB
< Previous
1
2
...
25
26
27
28
29
30
31
32
Next >
Where Biogen Stands With Analysts
November 19, 2021
Tickers
BIIB
Tags
Analyst Ratings
Market News
BIIB
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 19, 2021
November 19, 2021
Tickers
ABCL
ACGL
AIG
AJG
Tags
BRP
RNR
SIRI
From
Benzinga
Novartis Has $21B From Roche Stake Sale - Which Company Is On Its M&A Radar?
November 18, 2021
Tickers
ALNY
BIIB
BMRN
DRNA
Tags
RHHBF
Briefs
INCY
From
Benzinga
3 Biotech Stocks That Have More Than Tripled so far This Year
November 18, 2021
Tickers
BIIB
BNTX
LLY
OCGN
Tags
LLY
PFE
OCGN
From
Motley Fool
European Regulator Votes Down Biogen's Alzheimer's Drug
November 17, 2021
Tickers
BIIB
Tags
General
Briefs
News
From
Benzinga
Jim Cramer Likes This Stock Over Cassava Sciences And Biogen
November 17, 2021
Tickers
BIIB
CRM
DOCS
LLY
Tags
Benzinga
LLY
mad money Lightning Round
From
Benzinga
Could Eli Lilly Leapfrog Biogen in This Market?
November 17, 2021
Tickers
BIIB
LLY
Tags
Market News
LLY
Recent Press Releases
From
Motley Fool
Europe OKs Biogen's Vumerity For Multiple Sclerosis
November 16, 2021
Tickers
BIIB
Tags
Benzinga
FDA
multiple sclerosis
From
Benzinga
The Daily Biotech Pulse: Kezar Jumps On Data, Biogen R&D Chief To Retire, Molecular Partners Wilts On COVID Trial Disappointment
November 16, 2021
Tickers
ABT
AMRN
APLS
BIIB
Tags
MDWD
NRXP
IBB
From
Benzinga
President Biden Nominates Robert Califf As New FDA Commissioner: Report
November 12, 2021
Tickers
BIIB
GOOG
Tags
News
Briefs
Government
From
Benzinga
Why Are Biogen Shares Gaining Today?
November 12, 2021
Tickers
BIIB
ESALF
ESALY
Tags
Market News
Benzinga
Trading Ideas
From
Benzinga
The Daily Biotech Pulse: J&J To Spin-off Consumer Health Business, AstraZeneca Earnings, Embattled Emergent To Buy Back Shares
November 12, 2021
Tickers
ADPT
AFIB
ANVS
ATHX
Tags
ADPT
Earnings
NEXI
From
Benzinga
Eisai Posts New Lecanemab Data From Mid-Stage Alzheimer's Trial
November 11, 2021
Tickers
BIIB
ESALF
ESALY
Tags
News
Briefs
ESALY
From
Benzinga
Is Compass Pathways Stock a Once-in-a-Lifetime Bargain?
November 11, 2021
Tickers
AXSM
BIIB
CMPS
JAZZ
Tags
CMPS
SAGE
BIIB
From
Motley Fool
The Daily Biotech Pulse: Eisai-Gilead Tout Positive Phase 2 Data For New Alzheimer's Treatment, Compugen Spikes On Bristol-Myers Investment, Vaxxinity Debuts
November 11, 2021
Tickers
APTO
APYX
BIIB
BLFS
Tags
Biotech
IPOs
BMY
From
Benzinga
3 Vaccine Stocks With Big Opportunities Outside of COVID-19
November 11, 2021
Tickers
ALNY
BIIB
BNTX
GSK
Tags
GSK
ALNY
VIR
From
Motley Fool
Hit By Slow Rollout, Biogen's Aduhelm Could Soon Find Itself In Price Competition: Reuters
November 10, 2021
Tickers
BIIB
LLY
RHHBF
RHHBY
Tags
Health Care
BIIB
Biotech
From
Benzinga
This Company Says Its New Topical Therapy Trials Bringing Hope to People Exposed to Biofilm Bacteria
November 09, 2021
Tickers
ABBV
AMGN
BIIB
HOTH
Tags
Biotech
Partner Content
UL
From
Benzinga
The Daily Biotech Pulse: Double Dose Of Positive Tidings For Merck, Alkermes Slips On Partial Termination Of J&J Licensing Deal, Amgen Migraine Drug Data
November 09, 2021
Tickers
ACHV
ACIU
AEMD
AGEN
Tags
ACIU
HSTO
VCEL
From
Benzinga
The Week Ahead In Biotech (Nov. 7-Nov. 13): Earnings Taper Off, Multiple Conference Presentations, IPOs And More
November 08, 2021
Tickers
ABUS
ACAD
ACIU
ADAP
Tags
CCXI
VBIV
Top Stories
From
Benzinga
Todos Medical Says It Wants to Outfox COVID-19 & Cancer Along With Rivals Pfizer & Merck With New Theranostic Approach
November 05, 2021
Tickers
AMZN
BIIB
GILD
JNJ
Tags
Todos Medical
Health Care
NNVC
From
Benzinga
What Investors Should Like About Eli Lilly's Q3 Update
November 04, 2021
Tickers
BIIB
LLY
Tags
Market News
LLY
Recent Press Releases
From
Motley Fool
Healthcare Stocks Subject to Government Policy
November 02, 2021
Tickers
ABBV
AMGN
BIIB
BNTX
Tags
AMGN
Government
DD
From
Benzinga
Cassava Stock Could Jump More Than 200 Times
November 01, 2021
Tickers
BIIB
SAVA
Tags
SAVA
Market News
Stocks to Buy
From
InvestorPlace
Biogen Beat Earnings and Raised Guidance. Here's Why I Still Wouldn't Buy the Stock
October 29, 2021
Tickers
BIIB
Tags
BIIB
Market News
From
Motley Fool
Will Chart Analysts Notice Bad Omen on Biogen's Chart
October 29, 2021
Tickers
BIIB
Tags
BZI/CROSS
Market News
Movers
From
Benzinga
Down 76%: Is Cortexyme Stock a Bargain?
October 28, 2021
Tickers
BIIB
CRTX
EXEL
LLY
Tags
EXEL
CRTX
Market News
From
Motley Fool
Cortexyme's Alzheimer's Drug Fails -- 2 Lessons for Investors
October 28, 2021
Tickers
BIIB
CRTX
LLY
Tags
Market News
CRTX
LLY
From
Motley Fool
Should Biogen Investors Be Preparing for the Worst?
October 27, 2021
Tickers
BIIB
BMY
GSK
NVS
Tags
BMY
BIIB
RHHBY
From
Motley Fool
Expert Ratings For Biogen
October 26, 2021
Tickers
BIIB
Tags
BIIB
Benzinga
BZI/AAR
From
Benzinga
< Previous
1
2
...
25
26
27
28
29
30
31
32
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.